Arcoma AB (ARCOMA) - Total Liabilities

Latest as of March 2026: Skr26.30 Million SEK ≈ $2.83 Million USD

Based on the latest financial reports, Arcoma AB (ARCOMA) has total liabilities worth Skr26.30 Million SEK (≈ $2.83 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Arcoma AB (ARCOMA) asset resilience to evaluate the company's liquid asset resilience ratio.

Arcoma AB - Total Liabilities Trend (2012–2025)

This chart illustrates how Arcoma AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Arcoma AB.

Arcoma AB Competitors by Total Liabilities

The table below lists competitors of Arcoma AB ranked by their total liabilities.

Company	Country	Total Liabilities
Investcorp Credit Management BDC Inc NASDAQ:ICMB	USA	$111.86 Million
Sidomulyo Selaras Tbk JK:SDMU	Indonesia	Rp116.09 Billion
City Chic Collective Ltd AU:CCX	Australia	AU$68.62 Million
Oylum Sinai Yatirimlar AS IS:OYLUM	Turkey	TL114.25 Million
VL E-Governance & IT Solutions Limited NSE:VLEGOV	India	Rs-456.97 Million
Northeast Electric Development Company Limited F:NE4H	Germany	€391.88 Million
Mahube Infrastructure Ltd JSE:MHB	South Africa	ZAC1.13 Million
Victoria Insurance Tbk PT JK:VINS	Indonesia	Rp62.26 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Arcoma AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Arcoma AB balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.12	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arcoma AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arcoma AB (2012–2025)

The table below shows the annual total liabilities of Arcoma AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.92 Million ≈ $2.36 Million	+3.76%
2024-12-31	Skr21.13 Million ≈ $2.27 Million	-36.56%
2023-12-31	Skr33.30 Million ≈ $3.58 Million	-38.84%
2022-12-31	Skr54.46 Million ≈ $5.86 Million	+54.57%
2021-12-31	Skr35.23 Million ≈ $3.79 Million	-22.57%
2020-12-31	Skr45.50 Million ≈ $4.90 Million	+19.28%
2019-12-31	Skr38.14 Million ≈ $4.10 Million	+2.43%
2018-12-31	Skr37.24 Million ≈ $4.01 Million	+36.52%
2017-12-31	Skr27.28 Million ≈ $2.94 Million	-19.55%
2016-12-31	Skr33.90 Million ≈ $3.65 Million	-1.26%
2015-12-31	Skr34.34 Million ≈ $3.69 Million	-8.40%
2014-12-31	Skr37.48 Million ≈ $4.03 Million	-35.77%
2013-12-31	Skr58.35 Million ≈ $6.28 Million	+31.57%
2012-12-31	Skr44.35 Million ≈ $4.77 Million	--

About Arcoma AB

ST:ARCOMA Sweden Medical Devices

Market Cap

$12.26 Million

Skr113.90 Million SEK

Market Cap Rank

#26627 Global

#560 in Sweden

Share Price

Skr7.96

Change (1 day)

-2.93%

52-Week Range

Skr6.92 - Skr9.80

All Time High

Skr25.60